NewsBenzinga“我们不知道风险是什么”：GLP-1药丸繁荣带动数百款应用，但研究滞后 “我们不知道风险是什么”：GLP-1药丸繁荣带动数百款应用，但研究滞后 Benzinga 2026.09.26 17:30 (GMT+0) Open on Benzinga Other news Nike Stock (NKE) Could Swing 8.3% on Q1 Earnings, Options Market Signals - TipRanks.com Insurers claim AI is already increasing healthcare costs TikTok agrees to pay at least $100M in Alabama settlement Here Is How to Play Accenture Stock After a New AWS Collaboration Meta’s Muse Could Be the Biggest Threat Google Has Faced in 20 Years Ciena Stock Heats Up After Evercore Upgrade. How $550 Could Be the Next Stop.
